Pfizer Recalls Some Lots Of Blood Pressure Drug Due To Potential Carcinogen
(Reuters) -Pfizer Inc said on Monday it was recalling some lots of blood pressure drug Accuretic and two authorized cheaper versions of the drug due to the presence of elevated levels of a nitrosamine, a potential cancer-causing impurity. Pfizer said https://www.pfizer.com/news/press-release/press-release-detail/pfizer-voluntary-nationwide-recall-lots-accuretictm it has not received any reports of adverse events related to the drug till…
